Steven L. Cohn, MD, FACP*
Although general internists and subspecialists are familiar with prescribing and managing medications in typical outpatient and inpatient venues, the perioperative period represents a challenging and often unfamiliar setting. This module will outline the principles, available evidence, and expert opinion to be considered when making perioperative management recommendations for some of the most commonly prescribed medications.
After completing the module, the participant should be able to:
- Analyze the risks and benefits underlying perioperative management of antiplatelet and anticoagulant medications.
- Recognize the importance of continuing most cardiovascular medications perioperatively.
- Recognize the importance of continuing most pulmonary medications perioperatively.
- Assess when stress dose steroids are indicated and manage other endocrine medications in the perioperative period.
- List the theoretical risks of continuing neuropsychiatric medications and decide whether or not to discontinue them.
- Identify and discontinue herbal medications that may adversely impact perioperative outcomes.
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Credit Designation Statement: The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release date: October 15, 2009. Expiration date: October 15, 2011.
*Director–Medical Consultation Service, Kings County Hospital Center, Clinical Professor of Medicine, SUNY Downstate, Brooklyn, New York.
Disclaimer: The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Supported by an educational grant from Merck & Co., Inc.
Print
Email
Bookmark us!